Live from the NIH registry
Studies recruiting near Cape Coral right now
Top 25 of 245 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Florida Cancer Specialists & Research Institute - South — Fort Myers, Florida (9.7 mi)
· Sponsor: Revolution Medicines, Inc.
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Advanced Retina Institute — Bonita Springs, Florida (25.0 mi)
· Sponsor: NexThera Co., Ltd.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Florida Cancer Specialists - SOUTH - SCRI - PPDS — Fort Myers, Florida (9.7 mi)
· Sponsor: Hoffmann-La Roche
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Innovative Research Institute — Port Charlotte, Florida (23.7 mi)
· Sponsor: Sparrow Pharmaceuticals
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Southwest Florida Proton Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Proton Collaborative Group
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fort Myers, FL Investigative Site 10076 — Fort Myers, Florida (9.7 mi)
· Sponsor: Colorado Prevention Center
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1165 — Fort Myers, Florida (9.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Akero Therapeutics, Inc
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: SCRI Development Innovations, LLC
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Peace River Cardiovascular Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Florida Cancer Specialists - South ( Site 7002) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
HealthPark Medical Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Medtronic Cardiovascular
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Cape Coral, Florida (6.3 mi)
· Sponsor: GlaxoSmithKline
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Florida Cancer Specialists — Cape Coral, Florida (6.3 mi)
· Sponsor: Pfizer
Quality of End-of-Life Care for Children With Cancer
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
N/A
Observational 2,425 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Fort Myers, Florida (9.7 mi)
· Sponsor: 89bio, Inc.
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Florida Cancer Specialists South — Fort Myers, Florida (9.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1020 — Bonita Springs, Florida (25.0 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (9.7 mi)
· Sponsor: Merus B.V.
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
544 — Fort Myers, Florida (9.7 mi)
· Sponsor: Corcept Therapeutics
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Alliance for Multispecialty Research - Fort Myers — Fort Myers, Florida (9.7 mi)
· Sponsor: Amgen
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 100 participants sought
Neurocrine Clinical Site — Port Charlotte, Florida (23.7 mi)
· Sponsor: Neurocrine Biosciences